Article ID Journal Published Year Pages File Type
3269751 HPB 2011 8 Pages PDF
Abstract
These findings support a combination approach using multi-target antiangiogenic agents such as sunitinib with standard gemcitabine therapy in the treatment of PDAC.
Keywords
Related Topics
Health Sciences Medicine and Dentistry Endocrinology, Diabetes and Metabolism
Preview
Antitumour activity of sunitinib in combination with gemcitabine in experimental pancreatic cancer
Authors
, , ,